Consequently, the effect of pharmacological inhibition of CPT1 by etomoxir was evaluated in the experimental autoimmune encephalomyelitis (EAE) animal model of MS (Fig. 1a). The gene discussed is CPT1A; the disease is experimental autoimmune encephalomyelitis.